THE USE OF MEMANTINE AND BRIMONIDINE TO ATTENUATE VITREORETINAL VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) PROTEIN LEVELS IN ANIMALS

摘要

Reducing the VEGF level in a patient suffering from an ocular disease orcondition which is characterized by elevated VEGF and/or blood retina barrier(BRB) breakdown which comprises treating said patient with an effective amountof a compound selected from the group consisting of memantine, brimonidine andmixtures thereof.